Option Care Health (NASDAQ:OPCH) Earns “Market Outperform” Rating from JMP Securities

Option Care Health (NASDAQ:OPCHGet Free Report)‘s stock had its “market outperform” rating reiterated by investment analysts at JMP Securities in a research report issued on Wednesday,Benzinga reports. They presently have a $36.00 price target on the stock. JMP Securities’ target price suggests a potential upside of 14.07% from the stock’s previous close.

A number of other analysts have also recently weighed in on OPCH. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. increased their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Finally, UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $35.50.

Check Out Our Latest Report on Option Care Health

Option Care Health Stock Down 0.9%

Shares of NASDAQ:OPCH opened at $31.56 on Wednesday. The stock has a market capitalization of $5.17 billion, a price-to-earnings ratio of 25.45, a price-to-earnings-growth ratio of 1.91 and a beta of 0.74. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53. The company’s fifty day moving average is $32.08 and its two-hundred day moving average is $30.48. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54.

Option Care Health (NASDAQ:OPCHGet Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same period in the prior year, the company earned $0.26 earnings per share. The firm’s revenue was up 16.3% compared to the same quarter last year. Equities analysts anticipate that Option Care Health will post 1.22 EPS for the current year.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently bought and sold shares of OPCH. Rhumbline Advisers grew its position in Option Care Health by 3.3% in the 4th quarter. Rhumbline Advisers now owns 564,518 shares of the company’s stock valued at $13,097,000 after buying an additional 18,237 shares in the last quarter. State of New Jersey Common Pension Fund D boosted its position in shares of Option Care Health by 52.1% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 96,204 shares of the company’s stock valued at $2,232,000 after purchasing an additional 32,972 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Option Care Health by 0.9% during the 4th quarter. Principal Financial Group Inc. now owns 479,255 shares of the company’s stock valued at $11,119,000 after purchasing an additional 4,166 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after purchasing an additional 4,561 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS boosted its position in shares of Option Care Health by 2.5% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 444,095 shares of the company’s stock valued at $10,303,000 after purchasing an additional 10,900 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Analyst Recommendations for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.